[go: up one dir, main page]

DE69534180D1 - Promotor der tie rezeptor protein kinase - Google Patents

Promotor der tie rezeptor protein kinase

Info

Publication number
DE69534180D1
DE69534180D1 DE69534180T DE69534180T DE69534180D1 DE 69534180 D1 DE69534180 D1 DE 69534180D1 DE 69534180 T DE69534180 T DE 69534180T DE 69534180 T DE69534180 T DE 69534180T DE 69534180 D1 DE69534180 D1 DE 69534180D1
Authority
DE
Germany
Prior art keywords
promoter
protein kinase
receptor protein
tie receptor
tie
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69534180T
Other languages
English (en)
Other versions
DE69534180T2 (de
Inventor
Kari Alitalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Licentia Oy
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Publication of DE69534180D1 publication Critical patent/DE69534180D1/de
Application granted granted Critical
Publication of DE69534180T2 publication Critical patent/DE69534180T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69534180T 1994-09-22 1995-09-22 Promotor der tie rezeptor protein kinase Expired - Fee Related DE69534180T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31071794A 1994-09-22 1994-09-22
US310717 1994-09-22
PCT/FI1995/000520 WO1996009381A1 (en) 1994-09-22 1995-09-22 Promoter for the receptor tyrosine kinase, tie

Publications (2)

Publication Number Publication Date
DE69534180D1 true DE69534180D1 (de) 2005-06-02
DE69534180T2 DE69534180T2 (de) 2006-03-02

Family

ID=23203808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534180T Expired - Fee Related DE69534180T2 (de) 1994-09-22 1995-09-22 Promotor der tie rezeptor protein kinase

Country Status (8)

Country Link
US (1) US5877020A (de)
EP (1) EP0783572B1 (de)
JP (1) JPH10506011A (de)
AT (1) ATE294236T1 (de)
AU (1) AU701568B2 (de)
DE (1) DE69534180T2 (de)
NO (1) NO971341L (de)
WO (1) WO1996009381A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756570B1 (fr) 1996-12-03 2002-09-27 Commissariat Energie Atomique Promoteur de la ve-cadherine et ses utilisations
US6350450B1 (en) 1997-09-19 2002-02-26 Genentech, Inc. TIE ligand homologue antibody
US5972338A (en) 1997-09-19 1999-10-26 Genentech, Inc. Tie ligands homologues
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6348350B1 (en) 1997-09-19 2002-02-19 Genentech, Inc. Ligand homologues
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
US6130207A (en) * 1997-11-05 2000-10-10 South Alabama Medical Science Foundation Cell-specific molecule and method for importing DNA into a nucleus
AU2001244509A1 (en) * 2000-03-30 2001-10-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treatment of conditions involving obstruction of blood flow
AU2002232439A1 (en) * 2000-11-29 2002-06-11 Glaxo Group Limited Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
US20090181092A1 (en) * 2004-07-16 2009-07-16 Spinal Restoration, Inc. Methods for Treating Joints and Discs with a Carrier Matrix and Cells
GB0423554D0 (en) * 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
GB0428082D0 (en) * 2004-12-22 2005-01-26 Welcome Trust The Ltd Therapeutic compounds
US7951819B2 (en) 2006-04-26 2011-05-31 Cancer Research Technology Limited Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
KR101666228B1 (ko) 2007-09-28 2016-10-13 인트렉손 코포레이션 생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도
ES2520940T3 (es) 2007-12-19 2014-11-12 Cancer Research Technology Limited Compuestos de pirido[2,3-b]pirazina 8-sustituida y su uso
GB0807609D0 (en) * 2008-04-25 2008-06-04 Cancer Rec Tech Ltd Therapeutic compounds and their use
US8815896B2 (en) 2010-02-01 2014-08-26 The Institute Of Cancer Research: Royal Cancer Hospital 1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
EP2956159A1 (de) 2013-02-14 2015-12-23 UCL Business Plc. Mittel zur induzierung von lymphangiogenese zur verwendung bei der behandlung von zystennierenerkrankungen
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07506242A (ja) * 1992-01-09 1995-07-13 ヘルシンキ　ユニバーシティ　ホルディング　リミテッド Ｔｉｅ，新規内皮細胞受容体チロシンキナーゼ
US5466596A (en) * 1992-08-25 1995-11-14 Mount Sinai Hospital Corporation Tissue specific transcriptional regulatory element

Also Published As

Publication number Publication date
JPH10506011A (ja) 1998-06-16
AU3474895A (en) 1996-04-09
AU701568B2 (en) 1999-02-04
NO971341D0 (no) 1997-03-21
ATE294236T1 (de) 2005-05-15
EP0783572B1 (de) 2005-04-27
NO971341L (no) 1997-05-14
EP0783572A1 (de) 1997-07-16
DE69534180T2 (de) 2006-03-02
US5877020A (en) 1999-03-02
WO1996009381A1 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
ATE309360T1 (de) Vaskularer endothelialer wachstumsfaktor 2
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE69837996D1 (de) Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE69836131D1 (de) Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
ATE256186T1 (de) Verwendungen von angiogenischer factor vegf145 in der behandlung von kardiovaskulaeren krankheiten
DK0464533T3 (da) Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
ATE303439T1 (de) Intrazelluläre isoform von interleukin-1 rezeptor antagonist
NO982181L (no) Type IX collagen og chimerer
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
DE59708511D1 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
DE69821227D1 (de) Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen
BR0012704A (pt) Anticorpos antitumor, proteìnas e usos dos mesmos
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
CA2200846A1 (en) Promoter for the receptor tyrosine kinase, tie
DE50015355D1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee